← Leaderboards
James Scott McMurray
University Of Wisconsin Madison
$233,082
Attributed
$233,082
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $79.1K · FY2005–06$100K$75K$50K$25K$0
'05
'06
Funding mix
By agency
NIH$233,082 · 3
By mechanism
R03$216,540 · 1
M01$16,542 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Matthew D Davis$3,872,794
- Diane G Heatley$215,447
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectHuman Therapy EvaluationReflux EsophagitisClinical ResearchPatient Oriented ResearchEpitheliomaGastrointestinal Disorder ChemotherapyLaryngoscopyLarynx DisorderLarynx NeoplasmsMiddle Childhood (6-11)Neoplasm /Cancer ChemotherapyNeoplasm /Cancer Relapse /RecurrenceOmeprazoleQuality Of LifeQuestionnairesRespiratory NeoplasmBehavior TherapyVirus Related Neoplasm /CancerCidofovirClinical TrialsCombination TherapyDrug Screening /Evaluation
Grant awards (6)
Quantifying Effects of Treatment of Pediatric Dysphonia$71,040
R03 · FY2006 · DC · contact PI
USE OF CIDOFOVIR IN THE TREATMENT OF RECURRENT RESPIRATORY PAPILLOMATOSIS$931
M01 · FY2006 · RR · contact PI
Quantifying Effects of Treatment of Pediatric Dysphonia$72,750
R03 · FY2005 · DC
USE OF CIDOFOVIR IN THE TREATMENT OF RECURRENT RESPIRATORY PAPILLOMATOSIS$6,367
M01 · FY2005 · RR
Quantifying Effects of Treatment of Pediatric Dysphonia$72,750
R03 · FY2004 · DC
Use of Cidofovir in the Treatment of Recurrent Respiratory Papillomatosis$9,244
M01 · FY2004 · RR